menu
The oligonucleotide synthesis, modification and purification services market is estimated to be worth USD 5.8 billion in 2030::Roots::
The oligonucleotide synthesis, modification and purification services market is estimated to be worth USD 5.8 billion in 2030::Roots::
The oligonucleotide synthesis, modification and purification services market is estimated to be worth USD 5.8 billion in 2030

The oligonucleotide synthesis, modification and purification services market is estimated to be worth USD 5.8 billion in 2030

The applications ofoligonucleotides are vast, even beyond the life science / pharma sector;however, owing to complexities associated with the synthesis and processing ofthese molecules, such operations are usually outsourced to capable CMOs

 

Roots Analysis is pleased to announce the publication of its recent study,titled, Oligonucleotide Synthesis,Modification and Purification Services Market: Focus on Research,Diagnostic and Therapeutic Applications, 2020-2030

 

The report features anextensive study of the current scenario and future potential of the customsynthesis, modification and purification services market for oligonucleotides,which are intended for research, diagnostic, and therapeutic applications. The study includes in-depthanalyses, highlighting the capabilities of service providers engaged in thisdomain. In addition to other elements, it includes:

§  A detailed review ofthe current status of the market with respect to oligonucleotide manufacturersfocused on research and diagnostic, and therapeutic applications.

§  A competitivenessanalysis of prominent oligonucleotide manufacturers, featuring insightfulpictorial summaries and representations.

§  Elaborate profiles ofkey players that offer a diverse range of capabilities for custom synthesis,modification and purification of oligonucleotides.

§  An analysis of thevarious partnerships pertaining to oligonucleotide manufacturing, which havebeen established in the recent past.

§  An analysis of thevarious expansion initiatives undertaken by service providers engaged in thisdomain.

§  A detailed analysisof completed, ongoing and planned clinical research studies of variousoligonucleotide-based drug products.

§  An estimate of theoverall, annual capacity for manufacturing oligonucleotides based on datareported by industry stakeholders in the public domain.

§  An informed estimateof the annual clinical and commercial demand for oligonucleotides.

§  A discussion onaffiliated trends, key drivers and challenges, under an elaborate SWOTframework.

§  A survey analysisfeaturing inputs solicited from various experts who are directly / indirectlyinvolved in providing custom synthesis, modification and purification servicesfor oligonucleotides.

§  A detailed marketforecast, featuring analysis of the current and projected future opportunityacross key market segments (listed below)

  • Type of Manufacturing 

§  Custom Manufacturing

§  Large-scale Manufacturing 

  • Type of Oligonucleotides Manufactured

§  Antisense Oligonucleotides

§  miRNAs

§  shRNAs

§  siRNAs

§  OtherOligonucleotides

  • Scale of Operation

§  Clinical

§  Commercial

  • Purpose of Production

§  In-house

§  Outsourced

  • Target Therapeutic Area

§  Autoimmune Disorders 

§ Cardiovascular Disorders

§ Genetic Disorders

§ Infectious Diseases

§ Metabolic Disorders

§ Neuromuscular Disorders

§ Oncological Disorders

§ Ophthalmic Disorders

§  Other Therapeutic Areas

  • Size of manufacturer

§  Small

§  Mid-sized

§  Large

  • Key Geographical Region 

§  NorthAmerica

§  Europe

§  Asia-Pacific and Restof the World

§  Transcripts ofinterviews held with the following senior level representatives of stakeholdercompanies

§  Joachim Bertram (Chief Scientific Officer and ManagingDirector, IBA Lifesciences)

§  Tobias Pohlmann (Founder and Managing Director, BianoScience)

 

Keycompanies covered in the report

§ Agilent Technologies

§ Ajinomoto Bio-PharmaServices

§ BioSpring

§ CordenPharma

§ Integrated DNATechnologies

§ Kaneka Eurogentec

§ LGC BiosearchTechnologies

§ Microsynth

§ Nitto Denko Avecia

§ Sigma Aldrich

§ Thermo FisherScientific

§ TrilinkBiotechnologies

 

Formore information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html

 

Other RecentOfferings

1.      ChinaBiopharmaceutical Contract Manufacturing Market, 2020-2030

2.      PharmaceuticalContinuous Manufacturing Market, 2020-2030

3.    PeptideTherapeutics: Contract API Manufacturing Market, 2020-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com